Eisai Alzheimer's Drug Discovery Foundation, Pharma Firms Form Biobank Alliance Roche, Shionogi, Janssen Pharmaceuticals, and Eisai will provide the charity with specimens from Alzheimer's disease patients who participated in clinical studies. PGDx, Eisai to Develop Next-Generation Sequencing Biomarker Assay The group will create a kitted next-generation sequencing tool that will help researchers and biopharma firms conduct biomarker discovery work on patient blood samples. AmoyDx, Eisai Form CDx Development Alliance Tokyo-based Eisai develops drugs primarily for the neurology and oncology markets, including treatments for Parkinson's disease and breast cancer. Bristol-Myers Squibb, H3 Biomedicine Form Cancer Immunotherapy Alliance H3, a subsidiary of Japanese drugmaker Eisai, is developing personalized cancer treatments targeting genomic alterations, including aberrant RNA splicing. Cancer Genetics Signs Biomarker Services Deal with H3 Biomedicine Cancer Genetics will provide the services to support H3's development of H3B-8800, a Phase I small molecule-based blood cancer drug candidate. Feb 16, 2016 Eisai, Sysmex to Develop Dx, CDx for Dementia Dec 17, 2014 Oncodesign, Eisai Reach Deal to Assess Eribulin Apr 3, 2014 Eisai Researchers Developing microRNA-based Diagnostic for Alzheimer's Disease Premium Jul 11, 2013 Seegene and Eisai's Eidia Partner on MDx Tests in Japan Premium Jul 1, 2013 Seegene Signs Japan Marketing Deal with Eidia Jan 10, 2013 Epizyme Taps Roche to Develop Cobas 4800 CDx for Epizyme/Eisai Lymphoma Drug Candidate Premium Jan 7, 2013 Epizyme, Eisai, Roche Partner to Develop CDx for Investigational Lymphoma Treatment Oct 10, 2012 Eisai to Dissolve Dx R&D Subsidiary as It Focuses on Personalized Medicine Oct 9, 2012 Foundation Medicine, Eisai Ink Personalized Med Alliance May 16, 2012 With Celgene Partnership Epizyme Hopes to Accelerate Personalized Epigenetic Drug Development Premium Apr 6, 2012 IP Update: Recent Patents Awarded to Thermo Fisher Scientific; Eisai; and More Premium Jul 1, 2011 Evotec to Use PhosphoScout Platform in Oncology Biomarker Alliance with Roche Premium May 4, 2011 Supreme Court Case on Script Data Sale Presents 'Gray Area' for PBM Personalized Rx Efforts Premium Apr 6, 2011 AACR Presentations Highlight BATTLE Trial as New Model for Biomarker-Based Drug Studies Premium Apr 1, 2011 Proteome Sciences Signs Contract with Takeda for Protein Biomarker Research Premium Feb 4, 2011 Proteome Sciences Inks Deal with Eisai for First Commercial Use of Alzheimer's Biomarker Panel Premium Feb 2, 2011 Eisai Invests in Development of Personalized Cancer Rx via Stake in Biotech Startup Premium Jan 31, 2011 Proteome Sciences Providing Biomarker Services to Eisai Jan 28, 2011 Eisai Creates US Subsidiary H3 Biomedicine with up to $200M Nov 18, 2010 Eisai Gains Access to Forma's Drug Screening Technology Load More Breaking News Children With Autism May Have Underdeveloped Gut Microbiomes, Metagenomic Analysis Finds Kiromic BioPharma Acquires InSilico Solutions Bio-Rad Laboratories, 10x Genomics Settle IP Lawsuits, Sign Global Cross-Licensing Agreement Scope Fluidics Obtains CE Mark for PCR-Based SARS-CoV-2 Panel MeMed COVID-19 Prognostic Test Receives CE Mark ERS Genomics Licenses CRISPR IP to Japan SLC The Scan Dropped Charges The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal. More Kids The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children. PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more. Purnell Choppin Dies Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.